We are live on ! Find out more
HMH

Hackensack Meridian Health Portfolio holdings

AUM $1.48B
1-Year Est. Return 21%
This Fund
S&P 500
This Quarter Est. Return
-14.65%
1 Year Est. Return
+21%
3 Year Est. Return
+53.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$899M
AUM Growth
-$59.4M
Cap. Flow
+$86.3M
Cap. Flow %
9.6%
Top 10 Hldgs %
99.62%
Holding
13
New
4
Increased
5
Reduced
2
Closed
–
Avg Time Held
1.2 quarters
Top 10 Avg Time Held
1.6 quarters
Top 20 Avg Time Held
1.2 quarters
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SPY icon
1
State Street SPDR S&P 500 ETF Trust
SPY
$824B
$270M 30.04%
715,936
+205,000
+40% +$84M
2021 Q4
2 quarters
VBR icon
2
Vanguard Morningstar Small-Cap Value ETF
VBR
$35.5B
$171M 19.06%
1,143,976
-285,000
-20% -$46.7M
2021 Q4
2 quarters
ACWI icon
3
iShares MSCI ACWI ETF
ACWI
$33.1B
$100M 11.15%
1,195,000
+245,000
+26% +$22.3M
2022 Q1
1 quarter
EEM icon
4
iShares MSCI Emerging Markets ETF
EEM
$31.4B
$93.4M 10.39%
2,330,000
– –
2021 Q4
2 quarters
GNR icon
5
State Street SPDR S&P Global Natural Resources ETF
GNR
$5.09B
$83.7M 9.31%
1,606,000
-34,000
-2% -$2.04M
2021 Q4
2 quarters
EFA icon
6
iShares MSCI EAFE ETF
EFA
$76.8B
$56.4M 6.28%
902,932
+2,932
+0.3% +$200K
2021 Q4
2 quarters
HYG icon
7
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.2B
$54.1M 6.02%
735,000
+125,000
+20% +$9.72M
2021 Q4
2 quarters
LQD icon
8
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$27B
$34.3M 3.82%
312,000
+87,000
+39% +$9.82M
2021 Q4
2 quarters
IBB icon
9
iShares Biotechnology ETF
IBB
$10.5B
$26.8M 2.98%
228,000
– –
2022 Q1
1 quarter
BLV icon
10
Vanguard Long-Term Bond ETF
BLV
$5.42B
$5.18M 0.58%
+65,000
New +$5.35M
2022 Q2
0 quarters
IVV icon
11
iShares Core S&P 500 ETF
IVV
$888B
$2.57M 0.29%
+6,775
New +$2.79M
2022 Q2
0 quarters
IJH icon
12
iShares Core S&P Mid-Cap ETF
IJH
$123B
$440K 0.05%
+9,670
New +$477K
2022 Q2
0 quarters
IJR icon
13
iShares Core S&P Small-Cap ETF
IJR
$105B
$410K 0.05%
+4,419
New +$439K
2022 Q2
0 quarters

Similar funds

Hackensack Meridian Health's Q2 2022 Portfolio in Review

As of Q2 2022, Hackensack Meridian Health held 13 positions worth $899M, down 6.2% from $958M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Hackensack Meridian Health deployed $86.3M of net new capital in Q2 2022, opening 4 new positions and adding to 5 existing holdings. Its largest new stake was Vanguard Long-Term Bond ETF: 65,000 shares worth $5.18M.

On the sell side, the largest reduction was Vanguard Morningstar Small-Cap Value ETF, an estimated $46.7M trimmed.

  • Hackensack Meridian Health's largest Q2 2022 buy was Vanguard Long-Term Bond ETF: 65,000 shares worth $5.18M.
  • Hackensack Meridian Health added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $84M increase.
  • Hackensack Meridian Health's biggest Q2 2022 reduction was Vanguard Morningstar Small-Cap Value ETF, cutting an estimated $46.7M.
  • Hackensack Meridian Health's ten largest holdings make up 100% of its $899M portfolio in Q2 2022.
  • Hackensack Meridian Health opened 4 new positions and closed 0 in Q2 2022.
  • Hackensack Meridian Health's portfolio value fell 6.2% quarter-over-quarter to $899M.

Based on Hackensack Meridian Health's 13F filing for Q2 2022, filed 15 Aug 2022.